IRIS
RUSSO, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.423
EU - Europa 1.432
AS - Asia 1.060
SA - Sud America 294
AF - Africa 246
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.474
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.349
IT - Italia 603
SG - Singapore 522
CN - Cina 375
BR - Brasile 276
IE - Irlanda 253
CI - Costa d'Avorio 175
DE - Germania 142
FI - Finlandia 79
UA - Ucraina 69
CA - Canada 63
RU - Federazione Russa 56
AT - Austria 45
KR - Corea 44
FR - Francia 41
SN - Senegal 41
GB - Regno Unito 27
NL - Olanda 26
VN - Vietnam 24
CZ - Repubblica Ceca 18
BE - Belgio 16
SE - Svezia 15
NG - Nigeria 14
AU - Australia 13
TR - Turchia 12
BD - Bangladesh 11
IN - India 9
AR - Argentina 8
PK - Pakistan 8
PT - Portogallo 8
UZ - Uzbekistan 8
CH - Svizzera 6
ES - Italia 6
IR - Iran 6
JP - Giappone 6
ZA - Sudafrica 6
BG - Bulgaria 5
IQ - Iraq 5
KZ - Kazakistan 5
NZ - Nuova Zelanda 5
PL - Polonia 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
GR - Grecia 4
HU - Ungheria 4
LB - Libano 4
CR - Costa Rica 3
HK - Hong Kong 3
KE - Kenya 3
KG - Kirghizistan 3
MX - Messico 3
TN - Tunisia 3
EG - Egitto 2
IL - Israele 2
JM - Giamaica 2
NO - Norvegia 2
NP - Nepal 2
PS - Palestinian Territory 2
PY - Paraguay 2
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
CO - Colombia 1
DZ - Algeria 1
EC - Ecuador 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
JO - Giordania 1
OM - Oman 1
RO - Romania 1
SA - Arabia Saudita 1
TW - Taiwan 1
Totale 5.474
Salva come PNG Salva come JPEG
Città #
Santa Clara 520
Chandler 435
Singapore 344
Dublin 244
Chicago 177
Abidjan 175
Catania 162
Houston 109
Boardman 105
Hefei 80
Jacksonville 69
Ashburn 63
Civitanova Marche 63
Nuremberg 63
Cambridge 61
Lawrence 61
Andover 55
Seoul 44
Helsinki 43
Dakar 41
Nanjing 38
Des Moines 34
Lappeenranta 32
Beijing 31
Toronto 28
Vienna 28
Bremen 27
Rome 25
Wilmington 23
Munich 22
Los Angeles 21
Pozzallo 19
Dong Ket 18
Falls Church 18
Ottawa 17
Brno 16
Council Bluffs 16
Acireale 15
Brussels 15
Columbus 15
The Dalles 15
Abuja 14
Nanchang 14
Shanghai 14
Saint Petersburg 13
São Paulo 12
Belo Horizonte 11
San Giovanni la Punta 11
Grafing 10
Rio de Janeiro 10
Tianjin 10
Mascalucia 9
Naples 9
Seattle 9
Messina 8
San Mateo 8
Campinas 7
Changsha 7
Dallas 7
Hebei 7
L'Île-Saint-Denis 7
Padova 7
San Francisco 7
Zhengzhou 7
Amsterdam 6
Jiaxing 6
Ragusa 6
Salvador 6
Bari 5
Bologna 5
Brooklyn 5
Espinho 5
Lanzhou 5
Maceió 5
Manassas 5
New York 5
Palermo 5
Porto Alegre 5
Redmond 5
Turin 5
Arcadia 4
Berlin 4
Florence 4
Fortaleza 4
Juiz de Fora 4
Maletto 4
Melbourne 4
Moscow 4
Nissoria 4
Norwalk 4
Quintano 4
Redwood City 4
Reggio Calabria 4
Sciacca 4
Shenyang 4
Sydney 4
Taizhou 4
Tokyo 4
Turku 4
Warsaw 4
Totale 3.769
Salva come PNG Salva come JPEG
Nome #
((2S)-N-2-methoxy-2-phenylethyl-6,7-benzomorphan compound (2S-LP2): Discovery of a biased mu/delta opioid receptor agonist 215
2DIs: a SBML compliant web platform for the design and modeling of immune system interactions 113
Computational modeling of immunologic response to immune checkpoint inhibitors in COVID-19 patients with and without cancer 110
A MapReduce Based Tool for the Analysis and Discovery of Novel Therapeutic Targets 106
In silico clinical trials: concepts and early adoptions 102
A Credibility Assessment Plan for an In Silico Model that Predicts the Dose-Response Relationship of New Tuberculosis Treatments 101
R- ed S-LP2: sintesi, molecular docking e valutazione farmacologica 99
Computational modelling in melanoma for novel drug discovery 98
Agent based modeling of the immune system: NetLogo, a promising framework 95
Agent based modeling of the effects of potential treatments over the blood-brain barrier in multiple sclerosis 95
A multi-step and multi-scale bioinformatic protocol to investigate potential SARS-CoV-2 vaccine targets 94
Boosting multiple sclerosis lesion segmentation through attention mechanism 91
A MapReduce tool for in-depth analysis of KEGG pathways: identification and visualization of therapeutic target candidates 89
The Potential of Computational Modeling to Predict Disease Course and Treatment Response in Patients with Relapsing Multiple Sclerosis 89
Combining agent based-models and virtual screening techniques to predict the best citrus-derived vaccine adjuvants against human papilloma virus 87
EpiMethEx: a tool for large-scale integrated analysis in methylation hotspots linked to genetic regulation 87
Credibility of In Silico Trial Technologies - A Theoretical Framing 86
Gene Silencing of Transferrin-1 Receptor as a Potential Therapeutic Target for Human Follicular and Anaplastic Thyroid Cancer 85
Abstract 5305: DNA methylation and gene expression in melanoma: A large-scale integrated analysis 83
A computational model to predict the immune system activation by citrus derived vaccine adjuvants 82
Toward computational modelling on immune system function 81
Evaluation of the efficacy of RUTI and ID93/GLA-SE vaccines in tuberculosis treatment: in silico trial through UISS-TB simulator 81
Agent based modeling of relapsing multiple sclerosis: A possible approach to predict treatment outcome 80
An agent based modeling approach for the analysis of tuberculosis - Immune system dynamics 80
Computational modeling of PI3K/AKT and MAPK signaling pathways in melanoma cancer 78
Gene expression and pathway bioinformatics analysis detect a potential predictive value of MAP3K8 in thyroid cancer progression 77
Computational modeling of the expansion of human cord blood CD133+ hematopoietic stem/progenitor cells with different cytokine combinations 77
PEAK: A Clever Python Tool for Exploratory, Regression, and Classification Data. A Case Study for COVID-19 76
Predicting the artificial immunity induced by RUTI® vaccine against tuberculosis using universal immune system simulator (UISS) 74
Computational modeling reveals MAP3K8 as mediator of resistance to vemurafenib in thyroid cancer stem cells 74
Combining Parallel Genetic Algorithms and Machine Learning to Improve the Research of Optimal Vaccination Protocols 72
In silico design of recombinant multi-epitope vaccine against influenza A virus 71
GPU accelerated analysis of treg-teff cross regulation in relapsing-remitting multiple sclerosis 70
Computational models to predict disease course and treatment response in multiple sclerosis 69
Moving forward through the in silico modeling of tuberculosis: a further step with UISS-TB 68
Beyond the state of the art of reverse vaccinology: predicting vaccine efficacy with the universal immune system simulator for influenza 68
Design and optimization of PEGylated nanoparticles intended for Berberine Chloride delivery 66
Reverse Vaccinology for Influenza A Virus: From Genome Sequencing to Vaccine Design 65
Introducing scale factor adjustments on agent-based simulations of the immune system 64
PETAL: A Python tool for deep analysis of biological pathways 64
Advancing PFAS risk assessment: Integrative approaches using agent-based modelling and physiologically-based kinetic for environmental and health safety 63
BIOESOnet: A Tool for the Generation of Personalized Human Metabolic Pathways from 23andMe Exome Data 63
Computational modelling approaches to vaccinology 62
In silico evaluation of daclizumab and vitamin D effects in multiple sclerosis using agent based models 62
Using Continuous Petri Nets to predict the impact of microRNA analysis in PI3K/Akt and MAPK Signaling Pathways 61
ODEs approaches in modeling fibrosis. Comment on "Towards a unified approach in the modeling of fibrosis: A review with research perspectives" by Martine Ben Amar and Carlo Bianca 61
Computational immunogenetics 60
Generation of digital patients for the simulation of tuberculosis with UISS-TB 60
How can we accelerate COVID-19 vaccine discovery? 60
Modeling biology spanning different scales: An open challenge 59
A multi-step and multi-scale bioinformatic approach to investigate potential source of cross-reactive immunity against SARS-CoV-2 UK variant 57
Immune-checkpoint inhibitors from cancer to COVID‑19: A promising avenue for the treatment of patients with COVID‑19 (Review) 56
Optimization and analisys of vaccination schedules using simulated annealing and agent based models 55
The combination of artificial intelligence and systems biology for intelligent vaccine design 55
Toward a Regulatory Pathway for the Use of in Silico Trials in The Ce Marking of Medical Devices 54
Exploiting Stochastic Petri Net formalism to capture the Relapsing Remitting Multiple Sclerosis variability under Daclizumab administration 54
Computational identification of differentially-expressed genes as suggested novel COVID-19 biomarkers: A bioinformatics analysis of expression profiles 52
Model verification tools: a computational framework for verification assessment of mechanistic agent-based models 52
Computational modelling and simulation for immunotoxicity prediction induced by skin sensitisers 51
Scientific and regulatory evaluation of mechanistic in silico drug and disease models in drug development: Building model credibility 51
Modeling PI3K/PDK1/Akt and MAPK Signaling Pathways using Continuous Petri Nets 50
In silico trial to test COVID-19 candidate vaccines: a case study with UISS platform 48
Translatability and transferability of in silico models: Context of use switching to predict the effects of environmental chemicals on the immune system 47
Enhancing Multiple Sclerosis Lesion Segmentation in Multimodal MRI Scans with Diffusion Models 46
Moving forward through the in silico modeling of multiple sclerosis: Treatment layer implementation and validation 45
Genetic Algorithm-Based Prediction of Emerging SARS-CoV-2 Variants: A Computational Biology Perspective 44
Possible Contexts of Use for In Silico trials methodologies: a consensus- based review 44
Computational modeling approach to suggest possible therapeutic interventions in spinal muscular atrophy 42
Text mining and word embedding for classification of decision making variables in breast cancer surgery 39
Universal Immune System Simulator Analysis: The Impact of the Variable Approach Technique® on Enhancing Immune Defense Against infectious diseases 39
Modeling and Simulation of anakinra effects on severe COVID19 Patients 39
Quality by design tools reducing the gap from bench to bedside for nanomedicine 38
Cutaneous Leishmaniasis: discovering new effective therapies using the Universal Immune System Simulator 37
In silico clinical trials for relapsing-remitting multiple sclerosis with MS TreatSim 37
Modeling Cutaneous Leishmaniasis: Insights into M1/M2 Macrophage Dynamics Using the Universal Immune System Simulator 36
Genetic algorithm application for the prediction of potential SARS-CoV-2 new variant of concern 36
Uncertainty quantification and sensitivity analysis for in silico trial platform: A preliminary application on UISS-MS 36
UISS-GPU: Accelerated In-Silico Tuberculosis Vaccine Trials Using FLAME GPU 33
Verification of an agent-based disease model of human Mycobacterium tuberculosis infection 33
Machine Learning techniques application to predict the quality of life degree in breast cancer patients 33
Toward computational modelling on immune system function 32
Evaluation of word embedding models to extract and predict surgical data in breast cancer 31
Predictive Modelling of Allergic Responses to Chemical Sensitizers: Distinguishing Skin and Respiratory Reactions 29
Model Credibility 28
Generation of digital patients for the simulation of tuberculosis with UISS-TB 28
Pioneering bioinformatics with agent-based modelling: an innovative protocol to accurately forecast skin or respiratory allergic reactions to chemical sensitizers 27
Comment on “A decade of thermostatted kinetic theory models for complex active matter living systems” by Carlo Bianca 22
Modeling, simulation and prediction of protein structures for the design of oncolytic viruses 22
Model Development 20
In vitro approaches to investigate the effect of chemicals on antibody production: the case study of PFASs 19
Novel computational strategies for the identification of new therapeutic targets in melanoma and thyroid cancer. 19
Verify: A toolbox for deterministic verification of computational models 11
MSLesSeg: baseline and benchmarking of a new Multiple Sclerosis Lesion Segmentation dataset 8
Totale 5.708
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.735
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.735
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021288 12 11 24 13 75 25 34 3 29 12 19 31
2021/2022479 48 57 4 13 84 9 62 26 35 20 14 107
2022/20231.111 72 81 23 163 98 173 7 178 217 14 39 46
2023/2024816 32 177 42 21 19 126 22 75 8 111 111 72
2024/20252.328 62 307 128 165 462 297 267 65 117 176 137 145
2025/2026240 240 0 0 0 0 0 0 0 0 0 0 0
Totale 5.708